KESTRA MEDICAL TECHNOLOGIES, LTD. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +59.0%
EBITDA: -32.2%
EBIT: -26.7%
EPS: +33.5%
Free cash flow: -15.2%
Operating cash flow: -5.3%

Forward estimates

Revenue: +40.8%
EBITDA: +79.5%
EPS: +13.8%

Three-year CAGR

Revenue: +131.9%
EBITDA: -53.1%
EBIT: -26.7%
Net income: -15.6%
EPS: +52.6%
Free cash flow: -15.2%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.